Data Sharing Project Part 2

Sponsor
King's College London (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05298514
Collaborator
(none)
32
6

Study Details

Study Description

Brief Summary

Patient data from clinical records are increasingly recognised as a valuable resource and a number of global initiatives exist to promote and enable the sharing of data. However, some mental health service-users have expressed concerns about the use of their data by services, but these have not been explored in depth and the acceptable limits of data sharing remain unclear. The purpose of the study is to present different approaches to data sharing, with examples taken from across the world, varying in levels of anonymity and amounts of data stored and shared, with a view to extracting relevant principles directly from mental health service users. The primary objective of this study is to understand from service-users the limits of acceptable pseudonymised data sharing and data collection methods. This will inform the wider scientific community about any emerging questions and issues on pseudonymised clinical data sharing. We aim to explore the level of benefit service-users would accept, in exchange for the level of pseudonymised data they provide. Additionally, this study aims to investigate what service-users consider "identifiable" data, for example whether they consider demographic or location data or purely their real name to be identifiable. This study will ensure service-user views are an integral contribution to future pseudonymised data sharing systems, maximising applicability and acceptability. This study will use qualitative methods, in the form of focus groups, to gather service-user views. Focus groups will consider what participants believe to be identifiable data, who should get access, how should individuals and/or companies get access, how should data be protected and whether these answers change if pertaining to mental health information. Focus group data will be analysed using thematic analysis. Themes produced will be presented to participants in a second focus group. Participants will be encouraged to expand or change anything.

Condition or Disease Intervention/Treatment Phase
  • Other: Not applicable - qualitative research study

Study Design

Study Type:
Observational
Anticipated Enrollment :
32 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Investigating Service User Opinions on Sharing Levels of Personal Information
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Mental health service user opinions on clinical data sharing as explored through qualitative focus groups questions [Through study completion, an average of 1 year]

    To understand the requirements of service users, on issues such as privacy, usability, and acceptability of different tiers of data sharing. Furthermore, to investigate what service-users consider "identifiable" data, for example whether they consider identifiable data to be demographic information, location data (consisting of relative and absolute data) or purely their real name. This will be achieved by conducting a focus group in which the participants will be asked about hypothetical models of data sharing and their opinions on it. This will be guided by a topic guide asking the following questions: What is data? What would you consider to be personally identifiable information? Who gets access? How should individuals and/or companies get access? How should data be protected? The focus group will be audio-recorded, transcribed and analysed (via thematic analysis) to answer the primary outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Individuals who have experience of using mental health services or experienced mental health difficulties in the past.

  • Aged 18 and above.

  • Able to give informed consent.

  • Ability to speak fluent English.

Exclusion Criteria:
  • If identified through C4C, participants whose care team specify concerns regarding taking part in the study.

  • People in whom significant concerns have been raised relating to risk, where risk refers to the extent to which an individual poses a threat to themselves (e.g. self-harm or suicidal intent).

  • Inability to give informed consent, as judged by the clinician responsible for a service user's ongoing care, where applicable.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • King's College London

Investigators

  • Principal Investigator: Til Wykes, Clinical Doc, King's College London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
King's College London
ClinicalTrials.gov Identifier:
NCT05298514
Other Study ID Numbers:
  • LRS/DP-21/22-26411
  • 310873
First Posted:
Mar 28, 2022
Last Update Posted:
Mar 28, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 28, 2022